Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Cancer Metastasis Rev. 2020 Sep;39(3):769–781. doi: 10.1007/s10555-020-09886-7

Figure 2:

Figure 2:

Clinical relevance of MDA-9/Syntenin in a wide spectrum of cancers: Expression analysis in patient’s samples and in vivo studies in animal models signify the role of MDA-9/Syntenin in cancer progression, risk of metastasis and overall survival (Figure adapted from Das SK et al, Advances in Cancer Research, Volume 144, 2019, Pages 137–191).